HORMEL FOODS CORP (HRL)       45.34  +0.03 (+0.07%)

45.34  +0.03 (+0.07%)

US4404521001 - Common Stock - Premarket: 45.35 +0.01 (+0.02%)


Fundamental Rating

6

Overall HRL gets a fundamental rating of 6 out of 10. We evaluated HRL against 104 industry peers in the Food Products industry. HRL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, HRL is valued expensive at the moment.




Profitability

Profitability Rating

7

HRL has a Return On Assets of 7.51%. This is better than the industry average of 6.01%.
HRL's Profit Margin of 8.03% is amongst the best of the industry. HRL does better than the industry average Profit Margin of 5.66%.

HRL has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for HRL.
HRL has a Return On Equity of 13.27%. This is comparable to the industry average of 14.51%.
VS Industry

ROA (7.51%) VS Industry: 65% outperformed.

0.13
26.84

ROE (13.27%) VS Industry: 46% outperformed.

0.23
82.65

Profit Margin (8.03%) VS Industry: 63% outperformed.

0.08
41.73

Valuation

Valuation Rating

1

The Price/Earnings Ratio is 24.78, which indicates a rather expensive current valuation of HRL.
The Forward Price/Earnings Ratio of 23.69 indicates a rather expensive current valuation of HRL.
With a price book ratio of 3.29, HRL is valued correctly.
Compared to an average industry Enterprise Value to EBITDA ratio of 14.47, HRL is valued in line with its industry peers.

Compared to an average industry Price/Earning Ratio of 22.13, HRL is valued slightly more expensive.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry price book ratio of 1.97, HRL is valued more expensive than its industry peers.
VS Industry

Price/Earnings (24.78) VS Industry: 37% outperformed.

541.00
5.60

Price/Book (3.29) VS Industry: 23% outperformed.

250.05
0.03

Enterprise Value/ EBITDA (17.48) VS Industry: 43% outperformed.

665.34
0.89

Growth

Growth Rating

4

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Earnings Per Share has been growing slightly by 5.78% over the past year.
The Earnings Per Share has been growing slightly by 2.98% on average over the past 5 years.
HRL is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 7.49% yearly.

HRL shows a small growth in Revenue. In the last year, the Revenue has grown by 9.42%.
The Revenue has been growing slightly by 6.33% on average over the past 5 years.
HRL is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 1.76% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.98% 1.7% 5.78% 4.61% 5.67% 6.2% 7.49%
Revenue6.33% 9.47% 9.42% 1.64% 2.2% 2.27% 1.76%

Health

Health Rating

8

HRL has a Current Ratio of 2.47. This indicates that HRL is financially healthy and has no problem in meeting its short term obligations.
HRL is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.80.
When comparing the Quick Ratio to an average industry Quick Ratio of 0.90, HRL is better placed than the average industry peer to meet its short term obligations.
An Altman-Z score of 4.80 indicates that HRL is not in any danger for bankruptcy at the moment.

The Altman-Z score of HRL is much better than the industry average of 2.21. HRL has a better rating than 85% of its industry peers.
HRL has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for HRL.
HRL has a Quick Ratio of 1.30. This is a normal value and indicates that HRL is financially healthy and should not expect problems in meeting its short term obligations.
The Debt to Equity ratio of HRL is in line with the industry averages.
VS Industry

Debt/Equity (0.44) VS Industry: 53% outperformed.

53.34
0.00

Quick Ratio (1.3) VS Industry: 71% outperformed.

0.01
48.00

Current Ratio (2.47) VS Industry: 76% outperformed.

0.01
49.63

Altman-Z (4.8) VS Industry: 85% outperformed.

-34.87
75.23

Dividend

Dividend Rating

5

The dividend of HRL is nicely growing with an annual growth rate of 7.83%!
HRL has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 2.47%, HRL has a reasonable but not impressive dividend return.
HRL's Dividend Yield is comparable with the S&P500 average which is at 2.41.

55.78% of the earnings are spent on dividend by HRL. This is a bit on the high side, but may be sustainable.
HRL's Dividend Yield is slightly below the industry average, which is at 2.97.
The dividend of HRL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (2.47%) VS Industry: 34% outperformed.

0.73
17.92

HORMEL FOODS CORP45.34

NYSE:HRL (2/1/2023, 7:19:32 PM)+0.03 (+0.07%)

Premarket: 45.35 +0.01 (+0.02%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 11-30 2022-11-30/bmo Earnings (Next) 02-27 2023-02-27
Inst Owners 40.07% Inst Owner Change -0.17%
Ins Owners 47.17% Ins Owner Change 0.01%
Market Cap 24.77B Analysts 54
Price Target 47.16 (4.01%)

Dividend
Dividend Yield 2.47% Dividend Growth 7.83%
DP 55.78% Ex-Date 01-13 2023-01-13 (0.275)

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -0.93%
Min EPS beat(2) -3.19% Max EPS beat(2) 1.34%
EPS beat(4) 2 Avg EPS beat(4) -0.2%
Min EPS beat(4) -3.19% Max EPS beat(4) 1.34%
Revenue beat(2) 1 Avg Revenue beat(2) -1.46%
Min Revenue beat(2) -3.74% Max Revenue beat(2) 0.81%
Revenue beat(4) 2 Avg Revenue beat(4) 0%
Min Revenue beat(4) -3.74% Max Revenue beat(4) 2.99%
PT rev (1m) -0.3% PT rev (3m) -0.45%
EPS NQ rev (1m) 0% EPS NQ rev (3m) -4.53%
EPS NY rev (1m) 0% EPS NY rev (3m) -6.1%
Revenue NQ rev (1m) 0% Revenue NQ rev (3m) -1.29%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -2.21%

Valuation
Industry RankSector Rank
PE 24.78
Fwd PE 23.69
P/S 1.99
P/FCF 28.94
P/OCF 21.83
P/B 3.29
P/tB 30.72
EV/EBITDA 17.48
EPS(TTM) 1.83 EY 4.04%
EPS(NY) 1.91 Fwd EY 4.22%
FCF(TTM) 1.57 FCFY 3.46%
OCF(TTM) 2.08 OCFY 4.58%
SpS 22.8 BVpS 13.79
TBVpS 1.48 PEG (NY) 5.38
PEG (5Y) 8.31

Profitability
Industry RankSector Rank
ROA 7.51%
ROE 13.27%
ROIC 8.63%
ROICexc 9.43%
ROICexgc 24.88%
OM 10.32%
PM 8.03%
GM 17.37%
ROICexgc(3y) 25.06% ROICexcg growth 3Y -8.83%
ROICexcg growth 5Y -10.06% ROICexc(3y) 10.05%
ROICexc growth 3Y -13.48% ROICexc growth 5Y -12.1%
OM growth 3Y -5.39% OM growth 5Y -5.23%
PM growth 3Y -8% PM growth 5Y -2.77%
GM growth 3Y -4.33% GM growth 5Y -4.42%
F-Score 8 Asset Turnover 0.94

Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.85
Debt/EBITDA 2.13
Cap/Depr 106.15%
Profit Quality 85.61%
Current Ratio 2.47
Quick Ratio 1.3
Altman-Z 4.8
F-Score 8 WACC 7.39%
ROIC/WACC 3.37 Cap/Depr(3y) 128.83%
Cap/Depr(5y) 160.99% Profit Quality(3y) 84.67%
Profit Quality(5y) 80.5%

Growth
EPS 1Y 5.78% EPS 3Y 1.7%
EPS 5Y 2.98% EPS growth Q2Q 0%
EPS Next Y 4.61% EPS Next 2Y 5.67%
EPS Next 3Y 6.2% EPS Next 5Y 7.49%
Revenue growth 1Y 9.42% Revenue growth 3Y 9.47%
Revenue growth 5Y 6.33% Revenue growth Q2Q -4.96%
Revenue Next Year 1.64% Revenue Next 2Y 2.2%
Revenue Next 3Y 2.27% Revenue Next 5Y 1.76%
EBIT growth 1Y 19.6% EBIT growth 3Y 3.57%
EBIT growth 5Y 0.77% EBIT Next Year 26.25%
EBIT Next 3Y 12.05% EBIT Next 5Y N/A
FCF growth 1Y 11.25% FCF growth 3Y 10.81%
FCF growth 5Y 1.05% OCF growth 1Y 13.28%
OCF growth 3Y 7.13% OCF growth 5Y 1.88%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA